quantisnow
FeedTopReportsPricing
⌘K
Live feed
09:00:00·51d
PRRelease
Geron Corporation logo
Niagen Bioscience Inc. logo
Intellia Therapeutics Inc. logo
+1

Investors Eye Explosive Growth in Anti-Aging Therapies as Market Targets $420B Milestone

GERN· Geron CorporationNAGE· Niagen Bioscience Inc.NTLA· Intellia Therapeutics Inc.OCGN· Ocugen Inc.
Health Care
Original source

Companies

  • GERN
    Geron Corporation
    Health Care
  • NAGE
    Niagen Bioscience Inc.
    Health Care
  • NTLA
    Intellia Therapeutics Inc.
    Health Care
  • OCGN
    Ocugen Inc.
    Health Care

Recent analyst ratings

  • Mar 17OCGNUpdateCanaccord Genuity$12.00
  • Mar 11OCGNUpdateOppenheimer$10.00
  • Mar 2NTLAUpdateWilliam Blair-
  • Nov 12NTLAUpdateWolfe Research-
  • Nov 11NTLAUpdateEvercore ISI$8.00
  • Nov 7NTLAUpdateAnalyst$5.00

Related

  • PR17h
    Ocugen to Present at April 2026 Investor and Industry Conferences
  • PR1d
    Niagen Bioscience to Report First Quarter 2026 Financial Results on Wednesday, May 6, 2026
  • PR1d
    Geron Plans to Announce First Quarter 2026 Financial Results on May 6, 2026
  • SEC3d
    SEC Form PRER14A filed by Ocugen Inc.
  • PR3d
    Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
  • SEC6d
    SEC Form PRE 14A filed by Ocugen Inc.
  • INSIDER9d
    SEC Form 4 filed by Williams Timothy
  • INSIDER9d
    SEC Form 3 filed by new insider Williams Timothy
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022